Christopher Wilson, et al. A Genome Editing Lead Finding Platform for Therapeutics. Cambridge, MA.

Dec

9

Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting

Nov

6

Editas Medicine to Participate in Upcoming Investor Conferences

Nov

4

Editas Medicine Announces Third Quarter 2024 Results and Business Updates